CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway
Janina Graule(University of Bern), Inti Zlobec(University of Bern)
Cited by 88
Related Papers
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
Clinicopathological and protein characterization of <i>BRAF</i>‐ and <i>K‐RAS</i>‐mutated colorectal cancer and implications for prognosis
|International Journal of Cancer|2010|172